Increasing Mitochondrial Function on Skeletal Muscle Performance in Older Men
Launched by ROYAL DEVON AND EXETER NHS FOUNDATION TRUST · Jun 6, 2016
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
A defining feature of ageing is loss of muscle mass ('sarcopenia') and associated functional weakness ('dynapenia'). A common characteristic of dynapenia is lowered mitochondrial content and metabolic function, causing reduced aerobic capacity, increased sensations of effort and impaired lipid oxidation (with resultant glucose intolerance). Exercise training improves mitochondrial and muscle function in ageing populations, however such adaptations remain below that of young counterparts, suggesting alternative approaches are required. Pre-clinical studies show that dietary supplementation w...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male
- • Age between 65-75 years
- • Body mass index between 19-29
- • No active cardiovascular or metabolic disease
- • No active respiratory disease
- • No current musculoskeletal injuries
- • A sedentary lifestyle (i.e. does not engage in strenuous, planned physical activity)
- • The ability to give informed consent
- Exclusion Criteria:
- • Currently taking a statin drug or NSAIDs
- • Have a current peptic ulcer
- • Have any renal impairment
- • Have a known hypersensitivity to Acipimox
About Royal Devon And Exeter Nhs Foundation Trust
The Royal Devon and Exeter NHS Foundation Trust is a leading healthcare organization dedicated to delivering high-quality patient care and advancing medical research. Located in Exeter, the Trust is committed to innovation and excellence in clinical trials, facilitating studies that aim to improve health outcomes and enhance treatment options across various medical disciplines. With a strong emphasis on collaboration, the Trust partners with researchers, healthcare professionals, and patients to foster a research environment that prioritizes safety, ethical standards, and scientific integrity. Through its robust infrastructure and expertise, the Royal Devon and Exeter NHS Foundation Trust plays a vital role in the advancement of evidence-based medicine and the translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Exeter, Devon, United Kingdom
Patients applied
Trial Officials
Timothy Etheridge, PhD
Study Director
University of Exeter
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials